Arizona Tribune - Boulevard

NYSE - LSE

RBGPF	1.9%	69.89	$
CMSC	-0.31%	21.275	$
VOD	-1.19%	15.94	$
JRI	-0.32%	12.44	$
AZN	-2.04%	166.27	$
GSK	-1.24%	51.43	$
BCC	-1.38%	79.94	$
BTI	1.69%	57.44	$
RELX	-1.53%	35.34	$
RYCEF	1.65%	21.15	$
BP	-0.85%	42.5	$
BCE	-0.43%	23.49	$
RIO	-2.02%	104.7	$
NGG	-0.79%	80.53	$
CMSD	-0.47%	21.16	$

Featured

Search for missing after Nepal-Tibet floods kills at least 160

Rescue teams rushed Thursday to find hundreds of people missing on the Nepal-Tibet border in flash floods and landslides that killed at least 160 and swept away entire villages.

Police probe 'assault allegations' after Carse's nightclub incident

Derbyshire Police are looking into "allegations of assault" following the incident that saw England fast bowler Brydon Carse handcuffed outside a nightclub over the weekend.

Last news

Nikon ATX Pops Up in Austin This March

Nikon is Bringing its Innovative Energy to Austin, Inviting Creatives to Dive into Hands-on Photo Experiences, Learn from Leading Photographers, and be Inspired by the Vibrancy of the City

MIRA Pharmaceuticals Completes Phase 1 Dosing of Ketamir-2

Advancing a selective oral NMDA receptor modulator toward Phase 2a in chemotherapy-induced peripheral neuropathy following favorable Phase 1 safety and tolerability findings

Reggie Watts and Shane Mauss Headline Church of Ambrosia's 6th Annual 'Spirituality and Beyond' Easter Weekend Celebration

Three-day gathering brings comedy, music, consciousness exploration, and community to Oakland's Humanist Hall

InterContinental Hotels Group PLC Announces Transaction in Own Shares - March 04

Purchase of own shares

Polish doctors jailed for denying woman abortion

A Polish court on Tuesday sentenced three doctors to prison sentences over the 2021 death of a pregnant woman, which sparked nationwide protests and renewed scrutiny of the country's restrictive abortion laws.

2017 implosion of Argentine submarine was 'foreseeable,' trial hears

The submarine implosion that killed 44 Argentine sailors in November 2017, the country's worst naval disaster since the Falklands War, was "foreseeable," prosecutors argued as the trial over the disaster got underway Tuesday.

Rituals of resilience: how Afghan women stay sane in their 'cage'

They feel imprisoned "like a bird whose wings have been torn off" but struggle on, defiant in their own way.

Flowers, music, and soldiers at funeral of drug lord

The notorius Mexican drug lord Nemesio Oseguera was laid to rest in a simple grave Monday in a ceremony that featured trucks overflowing with flowers, traditional music and dozens of masked soldiers in armored vehicles.

Flo Health Publishes Groundbreaking Research on Economic Impact of Digital Tools for Endometriosis Care

Peer-reviewed study finds Flo Health's Symptom Checker could deliver nearly $10,100 in net monetary benefit per patient while cutting diagnosis wait time in half

Moderna Resolves Global Patent Litigation with Arbutus/Genevant

Moderna to pay $950 million with no future royalties to resolve all global litigation; corresponding charge expected in Q1 2026District Court's Section 1498 decision to be appealed to the Federal Circuit Court of Appeals with potential additional payment contingent on the outcome; no accrual recorded for potential additional payment as loss is not considered probable2026 year-end cash and cash equivalents now expected to be in the range of $4.5 - $5.0 billion

Reservoir Has Received Non-Binding Indication of Interest from Irenic Capital Management

No Shareholder Action Required at This Time

Dusk to Dawn Urgent Care Celebrates 25 Years of Service to Southern California

The Nation's First African American-Owned Urgent Care Chain Marks Milestone 25th Anniversary

What Patients Should Expect When Getting a Dental Filling in North Miami

NEW YORK CITY, NEW YORK / ACCESS Newswire / March 3, 2026 / Getting a dental filling is one of the most common dental treatments. If your dentist has told you that you need a filling, you probably want to know what will happen next. Knowing how things work can make you feel more prepared for the procedure. A North Miami dentist can walk you through each step so you know what to expect. Continue reading to learn more.

PID Floors Launches Official YouTube Playlist Dedicated to Hardwood Floor Care in Alignment with Official NWFA Standards

PID Floors' Brand-New Floor Care Mini-Video Series Offers Expert Guidance from the National Wood Flooring Association

SimiTree Appoints Technology Executive Zain Jafri as First-Ever Chief Product & Technology Officer

Newly created executive role reflects SimiTree's deepened commitment to technology vision, product innovation, and long-term growth strategy

Modular Medical Announces $12.0 Million Public Offering Priced at a Premium to Market

SAN DIEGO, CA / ACCESS Newswire / March 3, 2026 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced the pricing of a public offering with new and existing investors of 68,098,000 shares of its common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to an aggregate of 68,098,000 shares of its common stock at a combined public offering price of $0.1762 per share (or pre-funded warrant) and accompanying warrant. The warrants will have an exercise price of $0.1762 per share, will be exercisable immediately, and will expire five years from the date of issuance. The gross proceeds from the offering, before deducting placement agent fees and other offering expenses, are expected to be approximately $12.0 million. The closing of the offering is expected to occur on or about March 4, 2026, subject to the satisfaction of customary closing conditions.

Dolphin CEO Featured on Variety's "Strictly Business" Podcast, Discusses the Creator Economy's Transformation of Marketing and Consumer Product Launches

CEO Bill O'Dowd details Dolphin's evolution from production company to full-service marketing and entertainment powerhouse

Dr. Janak Parikh Named Castle Connolly Top Doctor in Plastic Surgery for 2026

Peer-nominated honor highlights Dr. Parikh's continued leadership in aesthetic and reconstructive plastic surgery across Houston and Lake Jackson.

Jaguar Health Secures an Additional $3 Million Payment from Future Pak for Mytesi and Canalevia-CA1

As announced, Jaguar received an up-front payment of $16M of non-dilutive capital in January 2026 upon entering U.S. license agreement with Future Pak for Mytesi® and Canalevia®-CA1 - Jaguar's two commercialized crofelemer drugs - an agreement that is fully aligned with company's strategy to concentrate crofelemer development efforts on human rare-disease intestinal failure indications

Black Book Releases 2026 PAIR Benchmark Ahead of HIMSS26, Quantifying "Last-Mile" Prior Authorization and Interoperability Readiness Across Payers, Providers, and Vendors

PAIR Benchmark scores overall readiness at 58/100, with ~35-40% provider-side manual fallback and only ~20% reporting SLO-grade monitoring and runbooks.

Kultura Brands, Inc. (OTCID:LTNC) Establishes Brokerage Account to Support Approved Investment Activities and Potential Share Repurchases

JACKSON, WYOMING / ACCESS Newswire / March 3, 2026 / Kultura Brands, Inc. (OTCID:LTNC) ("Kultura" or the "Company"), formerly known as Labor Smart, Inc., today announced that it has established a dedicated brokerage account with E*Trade from Morgan Stanley, to facilitate board-approved investment activities, including the potential purchase of its common stock in the open market, subject to applicable securities laws and regulations, including SEC and FINRA requirements, as well as the Company's internal compliance policies.

Babson Diagnostics Names Web Golinkin CEO

AUSTIN, TX / ACCESS Newswire / March 3, 2026 / Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, announced today that Web Golinkin, President and Chief Commercial Officer, has been named Chief Executive Officer and appointed to the company's Board of Directors. Mr. Golinkin succeeds David Stein, Ph.D., who has served as CEO since 2020. Dr. Stein assumes the role of Executive Director focused on strategic initiatives and will remain a member of the Board.

Aspire Biopharma Partners with Microsize to Develop Rapid-delivery Sublingual Powder Formulation of Alprazolam for Faster Anxiety Relief

Collaboration aims to create the first-ever sublingual alprazolam powder, addressing the need for faster-acting anxiety medication.Phase 1 clinical trial of the patent-pending, rapid-onset formulation planned for mid-2026.Alprazolam remains a top 40 prescribed medication in the US, with over 15.8 million prescriptions in 2023.

Ensysce Biosciences Announces First Peer-Reviewed Clinical Publication Demonstrating Oral Overdose Protection with MPAR(R) Technology

~ Phase 1 Data Published in Journal of Opioid Management Validates First-in-Class Overdose-Limiting Opioid Technology of PF614-MPAR ~

InterContinental Hotels Group PLC Announces Transaction in Own Shares - March 03

LONDON, UK / ACCESS Newswire / March 3, 2026 / The Company announces that on 02 March 2026 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 17 February 2026, as announced on 17 February 2026.

Ecuador launches joint anti-drug operations with US

Ecuador's President Daniel Noboa on Monday announced the launch of joint operations with the United States to combat drug trafficking, which has caused an explosion of violence in the South American country.

Bangladesh tackle gender barriers to reach Women's Asian Cup

Bangladesh's national football team face daunting odds at their first-ever Women's Asian Cup, but have already scored a major victory by qualifying.

Justera Announces Definitive Agreement to Sell Port North Extracts Inc. and Resignations

TORONTO, ON / ACCESS Newswire / March 2, 2026 / Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ("Justera" or the "Company") announces that it signed a definitive share and asset purchase agreement (the "Share and Asset Purchase Agreement") with 2657953 Ontario Inc. (the "Purchaser") to sell all of the issued and outstanding shares of its wholly owned subsidiary, Port North Extracts Inc. ("Port North") on February 26, 2026, subject to the terms and conditions set forth therein.

LogoTags, America's Leading Custom Challenge Coin Company and Fourth-Generation, Family-Owned Business, Proudly Sponsors the 2026 South Carolina Tri Series

MOUNT VERNON, NY / ACCESS Newswire / March 2, 2026 / Ball Chain Manufacturing Co., Inc.'s (Ball Chain) promotional products division, LogoTags, is proud to support the 2026 South Carolina Tri Series as an event sponsor. The races are produced by Set Up Events. Set Up Events was founded by Bill Scott in 1994. The company has established itself as one of the most prolific triathlon race production companies in the United States. The first event in the series of seven races will take place on April 19, 2026, at Lake Murray.

The Leadership Development Group and Northeast Georgia Health System Mark Six Years of Adaptive Leadership Development - Evolving from Physicians to Dyads to Apps

Demonstrating the power of adaptive design, NGHS and TLD Group celebrate six years of leadership growth across the health system.

Langjiu Launches Global Baijiu Tour in New York for Lunar New Year

The tour, which coincides with the Year of the Horse, included the "China Year · Shared with the World" Langjiu Spring Festival Night held at United Nations headquarters.

Bioxytran, Inc. Reports Positive Phase 1b/2a Clinical Study Results for ProLectin-M, a Broad-Range Antiviral Drug in Mild to Moderate COVID-19

BOSTON, MA / ACCESS Newswire / March 2, 2026 / Bioxytran, Inc. (OTCQB:BIXT), a clinical-stage biotechnology company developing carbohydrate-based therapeutics, today announced results from a randomized, double-blind, placebo-controlled Phase 1b/2a clinical study evaluating oral ProLectin-M in hospitalized patients with mild to moderate COVID-19 caused by SARS-CoV-2.

Arizona Tribune - Boulevard (English)